Status:
RECRUITING
Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
Lead Sponsor:
Seung-Jung Park
Collaborating Sponsors:
CardioVascular Research Foundation, Korea
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
19+ years
Brief Summary
The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.
Eligibility Criteria
Inclusion
- Patients ≥ 19 years old
- Patients receiving Xience-Skypoint™ stents.
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion
- Patients with a mixture of other DESs
- Terminal illness with life expectancy \<1 year
- Patients with cardiogenic shock
Key Trial Info
Start Date :
December 14 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05981911
Start Date
December 14 2023
End Date
December 1 2026
Last Update
January 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Hospital
Seoul, South Korea